Acute And Refractory Asthma Journals

Although severe, refractory asthma is an uncommon disease (likely < 5% of total asthma), it's poorly understood and, therefore, often frustrating to treat. What follows is that the proceedings of an American Thoracic Society (ATS)-sponsored workshop. The participants hope it will serve as an aid to begin to define, understand, and manage these refractory patients. Perhaps more importantly, it is also hoped that these proceedings will highlight the many questions that remain, and eventually lead to improved outcomes. Asthma affects 5–7% of the population of North America and Europe, and the prevalence is increasing (1, 2). Most asthma is mild or moderate (3) and can be well controlled with β-agonists with or without usual or low doses of antiinflammatory agents.    

High Impact List of Articles

Relevant Topics in General Science